Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study.
Liu K, Song Y, Xu G, Ye J, Wu Z, Liu X, Dong X, Zhang M, Xing Y, Zhu S, Chen X, Shen Y, Huang H, Yu L, Ke Z, Rosenfeld PJ, Kaiser PK, Ying G, Sun X, Xu X; PHOENIX Study Group.
Liu K, et al. Among authors: kaiser pk.
Am J Ophthalmol. 2019 Jan;197:156-167. doi: 10.1016/j.ajo.2018.08.026. Epub 2018 Aug 24.
Am J Ophthalmol. 2019.
PMID: 30148987
Clinical Trial.